Australia markets closed

BioRestorative Therapies, Inc. (BRTX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.2600-0.0300 (-2.33%)
At close: 04:00PM EDT
1.3100 +0.05 (+3.97%)
Pre-market: 08:14AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
130.2
-
119.8
46
77
130
Gross profit
127
-
-
-
-
-
Operating expenses
Research development
4,028
-
3,513
729.058
876.829
1,722
Selling general and administrative
12,785
-
15,580
25,625
1,952
6,840
Total operating expenses
16,635
-
18,983
26,354
2,829
8,562
Operating income or loss
-16,505
-
-18,864
-26,308
-2,752
-8,432
Interest expense
-
-
-
1,815
1,640
5,139
Total other income/expenses net
274.795
-
357.088
-16,180
-6,880
-1,077
Income before tax
-15,938
-
-18,495
-44,303
-11,273
-14,648
Income from continuing operations
-15,938
-
-18,495
-44,303
-11,273
-14,648
Net income
-15,938
-
-18,495
-44,303
-11,273
-14,648
Net income available to common shareholders
-15,938
-
-18,495
-44,303
-11,273
-14,648
Basic EPS
-4.03
-3.42
-5.11
-37.30
-15.75
-
Diluted EPS
-4.03
-3.42
-5.11
-37.30
-15.75
-
Basic average shares
3,962
4,218
3,618
1,188
715.543
-
Diluted average shares
3,962
4,218
3,618
1,188
715.543
-